Global Lysosomal Alpha Glucosidase Market Insights, Forecast to 2025

Table of Contents

1 Study Coverage

• 1.1 Lysosomal Alpha Glucosidase Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Lysosomal Alpha Glucosidase Market Size Growth Rate by Product
  • 1.4.2 AT-982
  • 1.4.3 ATB-200
  • 1.4.4 AVRRD-03
  • 1.4.5 JR-162
  • 1.4.6 MOSS-GAA
  • 1.4.7 OXY-2810
  • 1.4.8 Others
• 1.5 Market by End User
  • 1.5.1 Global Lysosomal Alpha Glucosidase Market Size Growth Rate by End User
  • 1.5.2 Glycogen Storage Disease
  • 1.5.3 Pompe Disease
  • 1.5.4 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Lysosomal Alpha Glucosidase Market Size
  • 2.1.1 Global Lysosomal Alpha Glucosidase Revenue 2014-2025
  • 2.1.2 Global Lysosomal Alpha Glucosidase Sales 2014-2025
• 2.2 Lysosomal Alpha Glucosidase Growth Rate by Regions
  • 2.2.1 Global Lysosomal Alpha Glucosidase Sales by Regions
  • 2.2.2 Global Lysosomal Alpha Glucosidase Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Lysosomal Alpha Glucosidase Sales by Manufacturers
  • 3.1.1 Lysosomal Alpha Glucosidase Sales by Manufacturers
  • 3.1.2 Lysosomal Alpha Glucosidase Sales Market Share by Manufacturers
  • 3.1.3 Global Lysosomal Alpha Glucosidase Market Concentration Ratio (CR5 and HHI)
• 3.2 Lysosomal Alpha Glucosidase Revenue by Manufacturers
  • 3.2.1 Lysosomal Alpha Glucosidase Revenue by Manufacturers (2014-2019)
  • 3.2.2 Lysosomal Alpha Glucosidase Revenue Share by Manufacturers (2014-2019)
• 3.3 Lysosomal Alpha Glucosidase Price by Manufacturers
• 3.4 Lysosomal Alpha Glucosidase Manufacturing Base Distribution, Product Types
  • 3.4.1 Lysosomal Alpha Glucosidase Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Lysosomal Alpha Glucosidase Product Type
  • 3.4.3 Date of International Manufacturers Enter into Lysosomal Alpha Glucosidase Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Lysosomal Alpha Glucosidase Sales by Product
• 4.2 Global Lysosomal Alpha Glucosidase Revenue by Product
• 4.3 Lysosomal Alpha Glucosidase Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Lysosomal Alpha Glucosidase Breakdown Data by End User

6 North America

• 6.1 North America Lysosomal Alpha Glucosidase by Countries
  • 6.1.1 North America Lysosomal Alpha Glucosidase Sales by Countries
  • 6.1.2 North America Lysosomal Alpha Glucosidase Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Lysosomal Alpha Glucosidase by Product
• 6.3 North America Lysosomal Alpha Glucosidase by End User

7 Europe

• 7.1 Europe Lysosomal Alpha Glucosidase by Countries
  • 7.1.1 Europe Lysosomal Alpha Glucosidase Sales by Countries
  • 7.1.2 Europe Lysosomal Alpha Glucosidase Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Lysosomal Alpha Glucosidase by Product
• 7.3 Europe Lysosomal Alpha Glucosidase by End User

8 Asia Pacific

• 8.1 Asia Pacific Lysosomal Alpha Glucosidase by Countries
  • 8.1.1 Asia Pacific Lysosomal Alpha Glucosidase Sales by Countries
  • 8.1.2 Asia Pacific Lysosomal Alpha Glucosidase Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Lysosomal Alpha Glucosidase by Product
• 8.3 Asia Pacific Lysosomal Alpha Glucosidase by End User

9 Central & South America

• 9.1 Central & South America Lysosomal Alpha Glucosidase by Countries
  • 9.1.1 Central & South America Lysosomal Alpha Glucosidase Sales by Countries
  • 9.1.2 Central & South America Lysosomal Alpha Glucosidase Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Lysosomal Alpha Glucosidase by Product
• 9.3 Central & South America Lysosomal Alpha Glucosidase by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Lysosomal Alpha Glucosidase by Countries
  • 10.1.1 Middle East and Africa Lysosomal Alpha Glucosidase Sales by Countries
  • 10.1.2 Middle East and Africa Lysosomal Alpha Glucosidase Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Lysosomal Alpha Glucosidase by Product
• 10.3 Middle East and Africa Lysosomal Alpha Glucosidase by End User

11 Company Profiles

• 11.1 Amicus Therapeutics Inc
  • 11.1.1 Amicus Therapeutics Inc Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Amicus Therapeutics Inc Lysosomal Alpha Glucosidase Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Amicus Therapeutics Inc Lysosomal Alpha Glucosidase Products Offered
  • 11.1.5 Amicus Therapeutics Inc Recent Development
• 11.2 Audentes Therapeutics Inc
  • 11.2.1 Audentes Therapeutics Inc Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Audentes Therapeutics Inc Lysosomal Alpha Glucosidase Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Audentes Therapeutics Inc Lysosomal Alpha Glucosidase Products Offered
  • 11.2.5 Audentes Therapeutics Inc Recent Development
• 11.3 Etubics Corp
  • 11.3.1 Etubics Corp Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Etubics Corp Lysosomal Alpha Glucosidase Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Etubics Corp Lysosomal Alpha Glucosidase Products Offered
  • 11.3.5 Etubics Corp Recent Development
• 11.4 Genzyme Corp
  • 11.4.1 Genzyme Corp Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Genzyme Corp Lysosomal Alpha Glucosidase Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Genzyme Corp Lysosomal Alpha Glucosidase Products Offered
  • 11.4.5 Genzyme Corp Recent Development
• 11.5 greenovation Biotech GmbH
  • 11.5.1 greenovation Biotech GmbH Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 greenovation Biotech GmbH Lysosomal Alpha Glucosidase Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 greenovation Biotech GmbH Lysosomal Alpha Glucosidase Products Offered
  • 11.5.5 greenovation Biotech GmbH Recent Development
• 11.6 Huons Co Ltd
  • 11.6.1 Huons Co Ltd Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Huons Co Ltd Lysosomal Alpha Glucosidase Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Huons Co Ltd Lysosomal Alpha Glucosidase Products Offered
  • 11.6.5 Huons Co Ltd Recent Development
• 11.7 JCR Pharmaceuticals Co Ltd
  • 11.7.1 JCR Pharmaceuticals Co Ltd Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 JCR Pharmaceuticals Co Ltd Lysosomal Alpha Glucosidase Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 JCR Pharmaceuticals Co Ltd Lysosomal Alpha Glucosidase Products Offered
  • 11.7.5 JCR Pharmaceuticals Co Ltd Recent Development
• 11.8 Oxyrane Belgium NV
  • 11.8.1 Oxyrane Belgium NV Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Oxyrane Belgium NV Lysosomal Alpha Glucosidase Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Oxyrane Belgium NV Lysosomal Alpha Glucosidase Products Offered
  • 11.8.5 Oxyrane Belgium NV Recent Development
• 11.9 Pharming Group NV
  • 11.9.1 Pharming Group NV Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Pharming Group NV Lysosomal Alpha Glucosidase Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Pharming Group NV Lysosomal Alpha Glucosidase Products Offered
  • 11.9.5 Pharming Group NV Recent Development
• 11.10 Sarepta Therapeutics Inc
  • 11.10.1 Sarepta Therapeutics Inc Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Sarepta Therapeutics Inc Lysosomal Alpha Glucosidase Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Sarepta Therapeutics Inc Lysosomal Alpha Glucosidase Products Offered
  • 11.10.5 Sarepta Therapeutics Inc Recent Development

12 Future Forecast

• 12.1 Lysosomal Alpha Glucosidase Market Forecast by Regions
  • 12.1.1 Global Lysosomal Alpha Glucosidase Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Lysosomal Alpha Glucosidase Revenue Forecast by Regions 2019-2025
• 12.2 Lysosomal Alpha Glucosidase Market Forecast by Product
  • 12.2.1 Global Lysosomal Alpha Glucosidase Sales Forecast by Product 2019-2025
  • 12.2.2 Global Lysosomal Alpha Glucosidase Revenue Forecast by Product 2019-2025
• 12.3 Lysosomal Alpha Glucosidase Market Forecast by End User
• 12.4 North America Lysosomal Alpha Glucosidase Forecast
• 12.5 Europe Lysosomal Alpha Glucosidase Forecast
• 12.6 Asia Pacific Lysosomal Alpha Glucosidase Forecast
• 12.7 Central & South America Lysosomal Alpha Glucosidase Forecast
• 12.8 Middle East and Africa Lysosomal Alpha Glucosidase Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Lysosomal Alpha Glucosidase Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details